Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 83901-83950 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06040632
IMPROVE-pT1: Accurate Allocation of Completion Resection in Early Colorectal Cancer
N/AActive, not recruiting
67 participants
Started: Sep 1, 2022 · Completed: Jul 31, 2027
3 conditions5 sponsors9 locations
NCT05516914
A Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant Tumors
PHASE1/PHASE2Recruiting
490 participants
Started: Sep 1, 2022 · Completed: Dec 30, 2025
1 condition1 sponsor19 locations
NCT05366309
Performance and Adherence in Children Using Spacers
NARecruiting
100 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT02808260
Predicting Development of SCAF in Device Patients
N/ARecruiting
500 participants
Started: Sep 1, 2022 · Completed: Sep 30, 2034
1 condition2 sponsors1 location
NCT06082401
Evaluating the Addition of Hemodiafiltration to EVLP - Impact on the Regeneration of Marginal Donor Lungs
NARecruiting
30 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05305820
Perioperative Exercise and Nutritional Optimisation Prehabilitation Before Surgery for Patients With Peritoneal Malignancy
NAActive, not recruiting
36 participants
Started: Sep 1, 2022 · Completed: Aug 1, 2024
5 conditions3 sponsors3 locations
NCT05309720
Dermal Substitution in Pediatric Burns
NARecruiting
20 participants
Started: Sep 1, 2022 · Completed: Nov 1, 2025
2 conditions1 sponsor1 location
NCT05706831
Music Intervention and Transcranial Electrical Stimulation for Neurological Diseases
NARecruiting
90 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2026
2 conditions3 sponsors1 location
NCT05544682
Cefiderocol in the Treatment of Multidrug-resistant Gram-negative Bacilli Infections, a Retrospective Study
N/ARecruiting
15 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2023
1 condition1 sponsor1 location
NCT05356117
Resistance Exercise Combined With Protein Supplementation in People With Pancreatic Cancer: The RE-BUILD Trial
NARecruiting
45 participants
Started: Sep 1, 2022 · Completed: Aug 15, 2026
1 condition1 sponsor1 location
NCT07031869
The Swedish Hockey League Hand and Wrist Injury Tracking Trial
N/AActive, not recruiting
200 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2025
6 conditions1 sponsor1 location
NCT05937243
Identifying Effective Technological-based Augmentations to Enhance Outcomes From Self-help Cognitive Behavior Therapy for Binge Eating
NAActive, not recruiting
76 participants
Started: Sep 1, 2022 · Completed: Aug 31, 2025
4 conditions1 sponsor1 location
NCT05496673
Meningitis: Burden, Causes, Screening and Prevention in Rural Northern Uganda
NARecruiting
11,100 participants
Started: Sep 1, 2022 · Completed: Sep 1, 2031
1 condition4 sponsors1 location
NCT05533697
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
361 participants
Started: Sep 1, 2022 · Completed: Feb 18, 2032
1 condition1 sponsor26 locations
NCT05230732
Neuromodulation of Inflammation and Endothelial Function
NARecruiting
158 participants
Started: Sep 1, 2022 · Completed: Feb 27, 2026
1 condition2 sponsors1 location
NCT05759117
Prospective Evaluation of Patients With Pleural Effusion
N/ARecruiting
1,000 participants
Started: Sep 1, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor2 locations
NCT05915208
Histiocytic Disorder Follow-up Study
N/ARecruiting
6,000 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2028
6 conditions1 sponsor1 location
NCT05554016
The UFO (Ultra Processed Foods in Obesity) Project
N/ARecruiting
200 participants
Started: Sep 1, 2022 · Completed: Feb 1, 2026
2 conditions1 sponsor1 location
NCT04442451
Mechanisms of Fatigability With Diabetes
NARecruiting
80 participants
Started: Sep 1, 2022 · Completed: Aug 31, 2027
2 conditions6 sponsors1 location
NCT05767203
Genetic Markers and Biomarkers in Patients With Intellectual Disabilities of Genetic Origin
NARecruiting
2,000 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2032
2 conditions1 sponsor1 location
NCT05530174
Effect of Single vs Multiple Prophylactic Antibiotic Doses on PJI Following Primary THA in Patients With a Fracture
NAActive, not recruiting
2,000 participants
Started: Sep 1, 2022 · Completed: Apr 1, 2025
4 conditions7 sponsors36 locations
NCT04814212
Drug-Coated Balloon in Anticoagulated and Bleeding Risk Patients Undergoing PCI
NARecruiting
546 participants
Started: Sep 1, 2022 · Completed: Jan 1, 2028
1 condition15 sponsors14 locations
NCT05767281
Comparative Evaluation of Dental Disease Prevention Programs
N/AActive, not recruiting
1,000 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06481358
Deep Learning-based Artificial Intelligence for the Diagnosis of Small Bowel Obstruction
N/AActive, not recruiting
17 participants
Started: Sep 1, 2022 · Completed: Oct 31, 2024
2 conditions1 sponsor1 location
NCT06095284
Prescribing Trends and Associated Outcomes of Antiepileptic Drugs in US Nursing Homes Surrounding the COVID-19 Pandemic
N/AEnrolling by invitation
22,500,000 participants
Started: Sep 1, 2022 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT06117878
Safety and Efficacy of NK510 to Treat Osteosarcoma and Soft Tissue Sarcoma
EARLY_PHASE1Recruiting
12 participants
Started: Sep 1, 2022 · Completed: Sep 1, 2024
2 conditions2 sponsors1 location
NCT06850493
Ketogenic Diet Prior to Bariatric Surgery
NARecruiting
46 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05523388
Role of Spinal Load in the Pathophysiology of Lumbar Spinal Stenosis
N/AActive, not recruiting
122 participants
Started: Sep 1, 2022 · Completed: Oct 31, 2026
1 condition2 sponsors1 location
NCT05558345
Expression of Stress Markers During Meth Treatment (EXPRESS+)
NARecruiting
55 participants
Started: Sep 1, 2022 · Completed: Mar 31, 2026
2 conditions2 sponsors1 location
NCT05485701
Perinatal Mental Health Study (PMHS) India
N/ARecruiting
2,332 participants
Started: Sep 1, 2022 · Completed: Aug 31, 2026
5 conditions3 sponsors2 locations
NCT05508841
Understanding How Alzheimer's Disease Impacts the Therapeutic Response to Transcranial Direct Current Stimulation
NARecruiting
42 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05436899
A Pilot Study on Training Simulator Efficacy
NARecruiting
36 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05353140
LAAO Versus NOAC in Patients with AF and PCI
NARecruiting
1,386 participants
Started: Sep 1, 2022 · Completed: Sep 20, 2029
2 conditions1 sponsor1 location
NCT05367687
A Study to Evaluate Camrelizumab Plus Rivoceranib (Apatinib) Versus Camrelizumab as Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or Ablation
PHASE2Active, not recruiting
251 participants
Started: Sep 1, 2022 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT05367011
Therapeutic Monitoring of Antibiotics in Intensive Care Patients: a Cohort Study PopTDM-ICU
N/ANot yet recruiting
2,500 participants
Started: Sep 1, 2022 · Completed: Sep 1, 2028
3 conditions1 sponsor0 locations
NCT05397574
Intraoperative Hyperspectral Imaging for Fluorescence Guided Surgery in Low Grade Gliomas
N/ARecruiting
60 participants
Started: Sep 1, 2022 · Completed: Jun 30, 2025
3 conditions1 sponsor1 location
NCT04981327
The API-CALF Study: Apixaban to Treat Calf Vein Thrombosis
PHASE3Not yet recruiting
1,300 participants
Started: Sep 1, 2022 · Completed: Aug 31, 2027
1 condition2 sponsors0 locations
NCT05612568
5 Years of Eye Screening for ARF in Children Aged <3 Years in Flanders
N/AActive, not recruiting
250,000 participants
Started: Sep 1, 2022 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05140239
Effects of Abrocitinib Treatment on Skin Barrier Function
N/AActive, not recruiting
20 participants
Started: Sep 1, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05574881
Dalpiciclib, Fulvestrant, Trastuzumab and Pertuzumab in HR Positive, HER2 Positive Metastatic Breast Cancer
PHASE1/PHASE2Active, not recruiting
72 participants
Started: Sep 1, 2022 · Completed: Jan 1, 2025
1 condition1 sponsor1 location
NCT05273346
TCM Conservative Treatment for the Degenerative Lumbar Spinal Stenosis
NAActive, not recruiting
94 participants
Started: Sep 1, 2022 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05610423
Covid-19 Vaccine Associated Myocarditis and Pericarditis in Norway
N/AEnrolling by invitation
100 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2032
1 condition3 sponsors1 location
NCT05530070
Cardiovascular Risk Factors in Coeliac Disease: a Series of Studies
NARecruiting
190 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05317130
A Complex Health Promotion Intervention in Parasport - The Safe & Healthy Parasport Project
N/ANot yet recruiting
150 participants
Started: Sep 1, 2022 · Completed: Sep 1, 2027
5 conditions2 sponsors1 location
NCT05488964
Effect of Exercise Training on Breastmilk Composition
NARecruiting
62 participants
Started: Sep 1, 2022 · Completed: Mar 31, 2028
1 condition1 sponsor1 location
NCT06453382
Development and Testing of a Sub-district Specific Model of 'Whole-of-government', and 'Whole-of-society' Approaches for the Prevention and Control of Non-communicable Diseases in a Sub-district of Bangladesh
NAActive, not recruiting
450 participants
Started: Sep 1, 2022 · Completed: Aug 31, 2024
4 conditions1 sponsor1 location
NCT05740111
The PREPAIRD Study: Personalized Surveillance for Early Detection of Pancreatic Cancer in High Risk Individuals
NAEnrolling by invitation
200 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2042
1 condition9 sponsors1 location
NCT05378425
A Study of NTX-1088, a Monoclonal Antibody Targeting the Poliovirus Receptor (PVR, CD155), as Monotherapy and Combined With Pembrolizumab
PHASE1Recruiting
90 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2026
5 conditions2 sponsors6 locations
NCT06975956
Evaluation of Sexual Function and Quality of Life Tests in Patients Who Underwent Manchester Operation for Pelvic Organ Prolapse
N/AActive, not recruiting
30 participants
Started: Sep 1, 2022 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT06169384
Endoscopic Partial Adenoidectomy Versus Total Adenoidectomy Regarding Rate of Recurrence and Relief of Symptoms
NARecruiting
60 participants
Started: Sep 1, 2022 · Completed: Jun 1, 2024
1 condition1 sponsor1 location